Management

EMIL BILLBÄCK

CHIEF EXECUTIVE OFFICER

Born: 1970
Employed since: 2018
Education: B.Sc. in Business Administration from Karlstad University. Extracurricular education at Georgetown University, IMD and Ashridge Business School.
Experience: Emil Billbäck has more than 25 years of experience in Life Science, most recently as Chief Commercial Officer at BSN Medical. He has had operational roles at Astra Zeneca and Beiersdorf, and that of Senior Strategic Advisor within ESSITY. Currently, he is a Board member at Doctrin and has previously been a Board member at ATOS. Emil Billbäck has lived and worked in the United States and in Germany.

Shareholding at December 31, 2024: 363,571 shares (own holding).

HÅKAN JOHANSSON

CHIEF FINANCIAL OFFICER

Born: 1963
Employed since: 2018
Education: B.Sc. in Business Administration from Mid Sweden University.
Experience: Håkan Johansson has more than 30 years of experience as CFO and other senior management roles from several industries in the public and private sectors. Prior to BONESUPPORT, he was CFO for Northern Europe at Thunstall Healthcare Group (2012-2018), a global company in security technology and system solutions for healthcare. He has previously also worked at toy manufacturer BRIO AB (publ) and Arctic Paper Group.

Shareholding at December 31, 2024: 75,290 shares (own holding).

MICHAEL DIEFENBECK

EVP MEDICAL & CLINICAL AFFAIRS CHIEF MEDICAL OFFICER

Born: 1974
Employed since: 2017
Education: MD. from Ludwig-Maximilians-University of Munich and Ph.D. from Friedrich Schiller University Jena. Certified orthopedic and trauma surgeon.
Experience: Founded Scientific Consulting in Orthopedic Surgery in 2014 and subsequently worked on several projects with BONESUPPORT as an independent medical advisor. He has 15 years of clinical experience from various hospitals in Germany, is the author of 32 published research articles in the field and is involved in the surgical education and training programs for students at Friedrich-Schiller-University Jena.

Shareholding at December 31, 2024: 108,160 shares (own holding).

FERGUS MACLEOD

GM & EVP COMMERCIAL OPERATIONS EUROW

Born: 1970
Employed since: 2019
Education: HND in Business and Finance from University of Bedfordshire and Executive Leadership Program, Center for Creative Leadership.
Experience: Fergus MacLeod has more than 20 years’ experience from international sales leadership positions in the orthobiology and medical equipment sectors with companies such as Johnson Matthey, RTI Surgical and Stryker.

Shareholding at December 31, 2024: 18,583 shares (own holding).

MIKE ROTH

GM & EVP COMMERCIAL OPERATIONS NORTH AMERICA

Born: 1963
Employed since: 2020
Education: BA degree in International Development from Clark University.
Experience: Michael Roth has over 25 years of experience with senior positions in both large and small companies active in orthopedics, with both direct and distributor-led sales. His most recent role before BONESUPPORT, was as Vice President of Sales and Marketing for Surgical Planning Associates (HipXpert). He has also served as Vice President of Sales for the Eastern Region at both Wright Medical and Microport Orthopaedics.

Shareholding at December 31, 2024: 31,733 shares (own holding).

HELENA BRANDT

EVP HUMAN RESOURCES

Born: 1965
Employed since: 2017
Education: M.Sc. in International Business and Economics from Lund University. Has also studied at the University of Cologne and at the University of Cincinnati and the University of Delaware.
Experience: Helena L Brandt is a senior HR leader with 25 years of experience in a wide range of industries, from Life Science to IT/Telecom. She has held global HR roles at Astra Zeneca, SonyEricsson and Tetra Pak, developing organizations, people, leaders, teams and cultures as well as driving transformation and change.

Shareholding at December 31, 2024: 15,956 shares (own holding).

Annelie Aava Vikner

EVP GLOBAL MARKETING

Born: 1971
Employed since: 2019
Education: B.Sc. in Chemistry from Linköping Institute of Technology at Linköping University and a post graduate certificate in Leadership from Glasgow Caledonian University.
Experience: Annelie Aava Vikner has close to 30 years’ of experience from marketing, sales and clinical trials in the field of medical technology & pharma. Previously, she has worked at Medtronic in different regional leading positions, mainly within marketing.

Shareholding at December 31, 2024: 12,480 shares (own holding).

MICHAEL WRANG MORTENSEN

EVP R&D AND OPERATIONS

Born: 1975
Employed since: 2021
Education: M.Sc. in Engineering from Technical University of Denmark, Ph.D. in Chemistry from University of Copenhagen and an executive MBA from the AVT Business School.
Experience: Michael Wrang Mortensen has more than 20 years of experience from the Medical Device and Healthcare industry with solid leadership and management experience within Innovation, Product Realization, Commercial Development and Operations. Prior to joining BONESUPPORT, he was Director for Development and Supply at Nanovi A/S. Before that, Michael held various management positions at Ferrosan Medical Devices A/S, innovating and developing combination products in partnership with large global players such as Ethicon Biosurgery Inc., Johnson & Johnson.

Shareholding at December 31, 2024: 25 000 shares (own holding).

ANNA STEGMARK

EVP QUALITY MANAGEMENT & REGULATORY AFFAIRS

Born: 1980
Employed since: 2024
Education: M.Sc. in Pharmacy, Uppsala University.
Experience: Before joining BONESUPPORT, Anna Stegmark worked for Radiometer and HemoCue where she gained nearly 20 years of experience in the Medical Device industry, holding positions in QA and RA. She has worked closely with stakeholders both in global operations, development, marketing, and sales and also worked with continuous improvements of quality management systems. During the past 15 years, Anna Stegmark has worked with leadership and developed both local and global teams. She has lived and worked in Sweden, Denmark and Switzerland which has given her an international experience.

Shareholding at December 31, 2024: 2,000 shares (own holding).